Oruka Therapeutics, Inc.

SEC 4 · Filed

0000907654-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 2, 2026

Exercise or conversion by Sandler Laura Lee

Security
Employee Warrant (right to buy)
Code
M
Shares
5,000
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-01-02",
  "direction": "D",
  "exercise_price": "7.80",
  "expiration": "2034-07-14",
  "footnotes": {
    "F5": "The warrant vests as to 1/4 of the underlying shares on April 3, 2025 and as to 1/48 of the underlying shares monthly from April 3, 2025."
  },
  "owners": [
    {
      "cik": "0002075401",
      "name": "Sandler Laura Lee",
      "roles": [
        "officer"
      ],
      "title": "Chief Operating Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "94996",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Employee Warrant (right to buy)",
  "shares": "5000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "5000"
}
Insider transactionsEvent date Jan 2, 2026

Sale by Sandler Laura Lee

Security
Common Stock
Code
S
Shares
1,108
Price per share
29.75Reported 29.7536
Structured facts
{
  "code": "S",
  "date": "2026-01-02",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025.",
    "F4": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.56 to $29.92, inclusive."
  },
  "owners": [
    {
      "cik": "0002075401",
      "name": "Sandler Laura Lee",
      "roles": [
        "officer"
      ],
      "title": "Chief Operating Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "205084",
  "price": "29.7536",
  "row": 4,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "1108",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 2, 2026

Sale by Sandler Laura Lee

Security
Common Stock
Code
S
Shares
3,144
Price per share
29.08Reported 29.0814
Structured facts
{
  "code": "S",
  "date": "2026-01-02",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025.",
    "F3": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.55 to $29.50, inclusive."
  },
  "owners": [
    {
      "cik": "0002075401",
      "name": "Sandler Laura Lee",
      "roles": [
        "officer"
      ],
      "title": "Chief Operating Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "206192",
  "price": "29.0814",
  "row": 3,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "3144",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 2, 2026

Sale by Sandler Laura Lee

Security
Common Stock
Code
S
Shares
8,748
Price per share
28.17Reported 28.166
Structured facts
{
  "code": "S",
  "date": "2026-01-02",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025.",
    "F2": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.55 to $28.52, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."
  },
  "owners": [
    {
      "cik": "0002075401",
      "name": "Sandler Laura Lee",
      "roles": [
        "officer"
      ],
      "title": "Chief Operating Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "209336",
  "price": "28.166",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "8748",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 2, 2026

Exercise or conversion by Sandler Laura Lee

Security
Common Stock
Code
M
Shares
5,000
Price per share
7.80
Structured facts
{
  "code": "M",
  "date": "2026-01-02",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {},
  "owners": [
    {
      "cik": "0002075401",
      "name": "Sandler Laura Lee",
      "roles": [
        "officer"
      ],
      "title": "Chief Operating Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "218084",
  "price": "7.8",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "5000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}